trending Market Intelligence /marketintelligence/en/news-insights/trending/zvlvkqsmbpenwqbnsn83ha2 content esgSubNav
In This List

Minerva Neurosciences names CEO as executive chairman

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Minerva Neurosciences names CEO as executive chairman

Minerva Neurosciences Inc. appointed CEO Rémy Luthringer as executive chairman after Marc Beer resigned to pursue other opportunities.

The company also appointed William Doyle as lead independent director. Doyle is executive chairman at NovoCure Ltd.